T1 Gene 801 804 ETS
T2 Protein 526 539 ERF deletions
T3 Condition 992 998 cancer
T6 Condition 1302 1317 prostate cancer
T7 Condition 886 923 prostate cancer tumor-suppressor gene
T8 Protein 526 529 ERF
T9 Protein 1293 1296 ERF
T10 Condition 1177 1192 prostate cancer
T13 Condition 252 267 prostate cancer
T14 Condition 79 85 cancer
T15 Condition 566 572 cancer
T17 Condition 1494 1500 cancer
T18 Level 270 291  African-American men
T20 Gene 999 1006 genomic
T21 Protein 1392 1396 PTEN
T23 Condition 502 508 cancer
T24 Gene 425 428 ETS
T25 Level 1195 1216  African-American men
T26 Condition 0 20 African-American men
T27 Condition 1311 1317 cancer
T28 Condition 311 325 gene mutations
T29 Protein 417 420 ERF
T30 Protein 530 539 deletions
T31 Condition 404 413 mutations
T32 Condition 578 587 mutations
T33 Condition 630 667 castration-resistant prostate cancers
T34 Condition 311 315 gene
T35 Condition 70 85 prostate cancer
T36 Protein 682 685 ERF
T37 Condition 886 901 prostate cancer
T39 Biomarker 820 828 androgen
T40 Cellular_component 157 162 Exome
T42 Gene 1155 1162 genomic
T43 Gene 425 454 ETS transcriptional repressor
T45 Protein 1381 1387 PIK3CA
T46 Protein 877 880 ERF
T48 Condition 557 572 prostate cancer
T49 Condition 930 934 gene
T51 Protein 591 600 deletions
T52 Condition 1302 1322 prostate cancer gene
T53 Condition 493 508 prostate cancer
T56 Condition 230 268 primary hormone-na√Øve prostate cancer 
T57 Condition 749 753 gene
